Total Payments
$3,263
2024 Payments
$1,016
Companies
24
Transactions
189
Medicare Patients
2,961
Medicare Billing
$226,167
Payment Breakdown by Category
Food & Beverage$3,263 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,263 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $680.95 | 27 | $0 (2024) |
| Novo Nordisk Inc | $458.94 | 29 | $0 (2024) |
| ABBVIE INC. | $454.33 | 38 | $0 (2024) |
| PFIZER INC. | $303.68 | 21 | $0 (2024) |
| Exact Sciences Corporation | $220.01 | 2 | $0 (2024) |
| Abbott Laboratories | $171.39 | 8 | $0 (2024) |
| Amgen Inc. | $162.56 | 11 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $156.48 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $107.46 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $94.19 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,016 | 61 | ABBVIE INC. ($191.08) |
| 2023 | $678.19 | 42 | ABBVIE INC. ($218.76) |
| 2022 | $402.30 | 27 | Bayer HealthCare Pharmaceuticals Inc. ($94.65) |
| 2021 | $174.41 | 12 | AstraZeneca Pharmaceuticals LP ($112.59) |
| 2020 | $11.47 | 1 | AstraZeneca Pharmaceuticals LP ($11.47) |
| 2019 | $178.31 | 13 | Abbott Laboratories ($28.58) |
| 2018 | $434.12 | 13 | AstraZeneca Pharmaceuticals LP ($245.27) |
| 2017 | $367.52 | 20 | AstraZeneca Pharmaceuticals LP ($182.75) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 2 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Endocrinology | ||||||
| 06/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.08 | General |
| 06/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: PAIN | ||||||
| 05/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Diabetes Care | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Obesity | ||||||
| 05/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardio-renal | ||||||
| 04/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: PAIN | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: VACCINE | ||||||
| 04/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Endocrinology | ||||||
| 03/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Biological | ||||||
| 03/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.68 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 607 | 1,080 | $199,710 | $52,158 |
| 2022 | 12 | 629 | 1,089 | $198,708 | $49,934 |
| 2021 | 16 | 713 | 1,225 | $206,827 | $57,873 |
| 2020 | 16 | 1,012 | 1,584 | $261,776 | $66,201 |
Total Patients
2,961
Total Services
4,978
Medicare Billing
$226,167
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 326 | $101,076 | $26,407 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 88 | 88 | $40,527 | $10,896 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 61 | $12,493 | $3,835 | 30.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $10,109 | $3,092 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 242 | $5,389 | $2,016 | 37.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 22 | $2,904 | $1,668 | 57.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $5,852 | $1,235 | 21.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 32 | $1,280 | $925.76 | 72.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 43 | 98 | $11,604 | $911.68 | 7.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 55 | 68 | $3,652 | $431.12 | 11.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $440.00 | $318.23 | 72.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 53 | 94 | $2,556 | $298.75 | 11.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,828 | $123.30 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 350 | $103,020 | $26,066 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $43,164 | $12,266 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 87 | $17,011 | $4,962 | 29.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 27 | 27 | $7,457 | $1,805 | 24.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 47 | 104 | $11,601 | $970.99 | 8.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 16 | 18 | $3,881 | $834.32 | 21.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $1,452 | $772.75 | 53.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,120 | $770.28 | 68.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 106 | 180 | $3,835 | $524.28 | 13.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 63 | 121 | $3,069 | $377.06 | 12.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 44 | 52 | $2,618 | $333.42 | 12.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 12 | 12 | $480.00 | $253.08 | 52.7% |
About Dr. Walter Kucaba, DO
Dr. Walter Kucaba, DO is a Family Medicine healthcare provider based in Duncan, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881787802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Kucaba, DO has received a total of $3,263 in payments from pharmaceutical and medical device companies, with $1,016 received in 2024. These payments were reported across 189 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,263).
As a Medicare-enrolled provider, Kucaba has provided services to 2,961 Medicare beneficiaries, totaling 4,978 services with total Medicare billing of $226,167. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Duncan, SC
- Active Since 10/02/2006
- Last Updated 02/03/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881787802
Products in Payments
- FARXIGA (Drug) $242.96
- BEVESPI AEROSPHERE (Drug) $232.44
- Cologuard Collection Kit (Device) $220.01
- VRAYLAR (Drug) $190.49
- QULIPTA (Drug) $167.13
- Kerendia (Drug) $156.48
- ELIQUIS (Drug) $122.55
- NURTEC ODT (Drug) $116.76
- Ozempic (Drug) $103.63
- UBRELVY (Drug) $94.49
- SYMBICORT (Drug) $87.94
- BREZTRI (Drug) $87.44
- FREESTYLE LIBRE 3 (Device) $79.94
- Tresiba (Drug) $76.15
- Rybelsus (Drug) $74.30
- Wegovy (Drug) $72.24
- Prolia (Biological) $64.37
- Otezla (Drug) $58.38
- Dexcom G6 Transmitter (Medical Supply) $57.81
- Veozah (Drug) $54.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Duncan
Mr. Michael Tanbonliong, Md, MD
Family Medicine — Payments: $15,207
Family Medicine $15,207
Francis Mcgouran, M.d, M.D
Family Medicine — Payments: $8,447
Family Medicine $8,447
Melissa Hurst, Md, MD
Family Medicine — Payments: $3,821
Family Medicine $3,821
Krystal Vonfeldt, Do, DO
Family Medicine — Payments: $3,584
Family Medicine $3,584
Antoinette Rhynes, Md, MD
Family Medicine — Payments: $3,317
Family Medicine $3,317
Dr. Jamie Cox, M.d, M.D
Family Medicine — Payments: $3,150
Family Medicine $3,150